Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide 200 µg
  • Aclidinium Bromide 400 µg
  • Birmingham, Alabama
  • +112 more
Mar 9, 2017

COPD, COPD Trial in Germany (QVA149, Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Ibbenbüren, Rheinland Pfalz, Germany
  • +17 more
Mar 14, 2017

COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )

Completed
  • Chronic Obstructive Pulmonary Disease
  • carmoterol (CHF 4226)
  • +2 more
  • Jonesboro, Arkansas
  • +49 more
Apr 7, 2017

Cachexia, COPD, Chronic Heart Failure Trial in Germany, Poland (oral nutrition supplement, food for special medical purposes)

Completed
  • Cachexia
  • +2 more
  • oral nutrition supplement, food for special medical purposes
  • Berlin, Germany
  • +3 more
Jan 30, 2017

COPD Trial in Canada, United States (Aclidinium bromide)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Birmingham, Alabama
  • +82 more
Nov 16, 2016

COPD Trial in Canada, United States (Aclidinium bromide, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Placebo
  • Birmingham, Alabama
  • +111 more
Nov 16, 2016

COPD Trial in Worldwide (Roflumilast, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Box Hill, Australia
  • +179 more
Oct 31, 2016

Quality of Life in Daxas-treated Patients Older Than 18 Years

Completed
  • Chronic Obstructive Pulmonary Disease
  • Ahlen, Germany
  • +604 more
Oct 27, 2016

COPD Trial in Germany (QVA149, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Koblenz, NRW, Germany
  • +29 more
Mar 7, 2016

COPD Trial in Germany (Indacaterol, Tiotropium, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aschaffenburg, Germany
  • +20 more
Feb 16, 2016

COPD Trial in Germany (NVA237, Tiotropium, Placebo to NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Berlin, Germany
  • +13 more
Dec 19, 2014

COPD Trial in Worldwide (NVA237, Tiotropium, Placebo to tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Toronto, Ontario, Canada
  • +75 more
Apr 22, 2014

COPD Trial in Worldwide (QVA149, Tiotropium, Placebo to QVA149)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Bruxelles, Belgium
  • +42 more
Nov 5, 2013

COPD Trial in Worldwide (QVA149, NVA237, tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Birmingham, Alabama
  • +344 more
Oct 29, 2013

Spiriva in Chronic Obstructive Pulmonary Disease

Completed
  • Chronic Obstructive Pulmonary Disease
    • Amberg, Germany
    • +176 more
    Nov 27, 2013

    COPD Trial in Worldwide (Indacaterol 150 µg, Tiotropium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Capital Federal, Buenos Aires, Argentina
    • +423 more
    Sep 16, 2013

    COPD Trial in Austria, Germany (QVA149, fluticasone/salmeterol)

    Withdrawn
    • Chronic Obstructive Pulmonary Disease
    • Feldkirch, Austria
    • +28 more
    Nov 8, 2013

    COPD Trial in United States (Arformoterol, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Birmingham, Alabama
    • +72 more
    Sep 12, 2013

    COPD Trial in Berlin (AZD9668)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Berlin, Germany
      Research Site
    Jan 28, 2013

    COPD Trial in Germany, Switzerland (budesonide/formoterol Turbuhaler 320/9µg, formoterol Turbuhaler 9µg, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • budesonide/formoterol Turbuhaler 320/9µg
    • +2 more
    • Berlin, Germany
    • +8 more
    Jul 27, 2012

    COPD Trial in Worldwide (Glycopyrronium bromide, Placebo to glycopyrronium bromide, Tiotropium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Glycopyrronium bromide
    • +2 more
    • Birmingham, Alabama
    • +138 more
    Aug 9, 2012

    COPD Trial in Worldwide (AZD9668, AZD9668 Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Fullerton, California
    • +104 more
    Jun 19, 2012

    COPD Trial in Worldwide (NVA237, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Spartanburg, South Carolina
    • +9 more
    Apr 10, 2012

    Emphysema, COPD Trial in Worldwide (BTVA System)

    Completed
    • Emphysema
    • Chronic Obstructive Pulmonary Disease
    • BTVA System
    • Chermside, Queensland, Australia
    • +9 more
    Feb 21, 2012

    COPD Trial in Worldwide (Indacaterol, Salmeterol/fluticasone (50/500 µg), Salbutamol (200 µg))

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Tamarac, Florida
    • +16 more
    Sep 7, 2011